drugset / Trial / NCT00868426

Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhaler

NCT00868426 ↗

Phase 1 Completed 12 enrolled Orion Corporation, Orion Pharma
RandomizedCrossoverOpen-label

Summary

The aim of this pilot study is to assess the methodology, practical arrangements and pulmonary absorption with charcoal blockage for the future bioequivalence studies. In addition, PK of budesonide and formoterol after administration from 2 different batches of Symbicort TH is compared with each other.

Timeline

Start
2009-04
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide/Formoterol Unknown — Inhaled

Indications

No indication recorded.